Empyrean Capital Partners’s Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant CCVI.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,800,000
Closed -$28.3M 204
2021
Q2
$28.3M Hold
2,800,000
0.65% 44
2021
Q1
$28.2M Buy
+2,800,000
New +$30.3M 0.81% 34

Other funds holding CCVI.U

Empyrean Capital Partners's CCVI.U Position: Q3 2021 in Review

Empyrean Capital Partners sold out of Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant (CCVI.U) in Q3 2021, closing a stake of 2,800,000 shares — an estimated $28.3M sold.

Empyrean Capital Partners first reported a position in CCVI.U in Q1 2021 and held it in 2 quarters. The position peaked at $28.3M in Q2 2021. 38 funds tracked by Wall St. Rank hold CCVI.U as of Q3 2021.

  • Empyrean Capital Partners reported no remaining Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 2,800,000 Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant shares in Q3 2021, an estimated $28.3M.
  • Empyrean Capital Partners first reported a position in Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant in Q1 2021 and held it in 2 quarters.
  • Empyrean Capital Partners's Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant position peaked at $28.3M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant as of Q3 2021.

Based on Empyrean Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.